Related Experiment Video
Updated: Jun 2, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Enhancing clinical decision-making: Sysmex UF-5000 as a screening tool for bacterial urinary tract infection in
Ping Liu1,2, Chuanwei Ban1,2, Juan Wang1,2
1Clinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Insights
The Sysmex UF-5000 flow cytometer effectively screens pediatric urine samples for urinary tract infections (UTIs), identifying negative cultures and significant bacterial growth. This rapid test aids in reducing unnecessary cultures and guiding early treatment decisions.
Area of Science:
- Clinical diagnostics
- Pediatric infectious diseases
- Microbiology
Background:
- Urinary tract infections (UTIs) in children require rapid screening tests to inform clinical decisions.
- Current methods often necessitate lengthy urine cultures, delaying diagnosis and treatment.
- A need exists for efficient tools to avoid unnecessary cultures and expedite patient care.
Purpose of the Study:
- To evaluate the Sysmex UF-5000 flow cytometer as a screening tool for UTIs in pediatric patients.
- To assess the analyzer's performance in detecting white blood cells (WBC) and bacteria (BACT) compared to urine culture results.
- To determine the utility of the UF-5000 in identifying negative cultures and significant bacterial growth.
Main Methods:
- Analysis of 4445 pediatric urine samples collected between January 2020 and September 2023.
- Measurement of urine WBC and BACT counts using the Sysmex UF-5000 flow cytometer.
- Comparison of UF-5000 findings with standard urine culture results to assess diagnostic accuracy.
Main Results:
- Optimal cut-offs for positive cultures were BACT at 92.2/μL (AUC: 0.944) and WBC at 40.8/μL (AUC: 0.863).
- A BACT cut-off of 7.8/μL achieved a 0.9% false negative rate, enabling avoidance of 28.1% of unnecessary cultures.
- The UF-5000 demonstrated higher consistency for Gram-negative (90.3%) than Gram-positive (86.8%) bacteria, with superior concordance for significant bacterial growth.
Conclusions:
- The Sysmex UF-5000 shows promise for screening pediatric urine cultures, identifying negative results and significant bacterial growth.
- The analyzer aids in reducing unnecessary cultures and can guide empirical antibiotic therapy, especially for Gram-negative UTIs.
- Performance may vary by study population, but Gram typing capability enhances clinical decision-making.
Background:
A rapid screening test for urinary tract infections (UTIs) in children is needed to avoid unnecessary cultures and provide prompt reports to make appropriate clinical decisions. We have evaluated for the first time the performance of the Sysmex UF-5000 flow cytometer as a screening tool for UTIs in children.
Methods:
This study included 4445 pediatric patients, with urinary sediment and urine culture data collected from January 2020 to September 2023. The Sysmex UF-5000 analyzer was utilized to measure urine white blood cell (WBC) and bacteria (BACT), with the findings being compared to the culture results.
Results:
At ≥ 104 colony-forming unit (CFU)/mL, 513 samples were culture-positive (400 samples presented 104-105 CFU/mL, and 113 demonstrated ≥ 105 CFU/mL bacterial growth). Optimal indicators for positive cultures were BACT counts of 92.2/μL (AUC: 0.944) and WBC counts of 40.8/μL (AUC:0.863). False negative rate were 0.9% when using a 7.8 bacteria/μL cut-off and avoiding unnecessary cultures in 28.1%. The UF-5000 has a higher consistency rate for Gram-negative (GN) bacteria (90.3%) than Gram-positive (GP) bacteria (86.8%). For samples with 105 CFU/mL, UF-5000's Bacteria -Information flags showed superior concordance for samples with 104-105 CFU/mL bacteria.
Conclusions:
Screening pediatric urine cultures with the UF-5000 showed potential application value in identifying negative cultures and significant bacterial growth, although performance may vary depending on the study population. Furthermore, detecting Gram typing aids in guiding early clinical empirical medication, particularly for UTIs caused by GN bacteria.
More Related Videos
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
12:08Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies II: Ultrasonography
Urine Studies II: Urine Culture and Sensitivity Test
Microbiota of the Urogenital Tract
Automated Microbial Diagnostics